Mpox Vaccine (JYNNEOS)
The mpox vaccine (JYNNEOS) is a 2-dose series, 28 days apart, recommended for adults aged 18 and older who are at risk of mpox infection. It uses a live virus that cannot copy itself in human cells.

Mpox (formerly monkeypox) is a viral illness with a distinctive rash that spreads through close contact, including sexual contact. Since the 2022 global outbreak, vaccination has been a central control measure for the groups most affected.
JYNNEOS is made from a weakened vaccinia virus (a relative of smallpox virus) that cannot replicate in human cells — so unlike the older smallpox vaccine, it can be used in many people with weakened immune systems. It is also used after exposure: vaccination within 4 days of exposure may prevent disease, and up to 14 days may reduce its severity.
What this vaccine protects against
- Mpox infection — fever, swollen glands and a progressive rash that becomes blister-like and scabbed.
- Severe mpox in people with weakened immune systems.
Who should get it, and when
Adults aged 18 years and older at risk of mpox infection should complete the 2-dose series, 28 days apart. The CDC schedule notes define risk around recent sexual exposure patterns — including a recent sexually transmitted infection diagnosis, more than one recent partner, sex at a commercial venue or large event where mpox is spreading — and include partners of people in those groups and people who anticipate such exposure.
People with occupational exposure, such as certain laboratory workers handling orthopoxviruses, are also covered.
After a known exposure, vaccination is ideally given within 4 days, and may still help up to 14 days after exposure.
Pregnancy: there is currently no ACIP recommendation for routine JYNNEOS use in pregnancy because of limited data; pregnant people with a risk factor may receive it after discussion with their clinician.
What happens at the vaccination visit
- A small injection, usually just under the skin of the upper arm (or into the muscle, depending on current guidance and site practice).
- Dose 2 follows 28 days later; if it is late, give it as soon as possible — the series is not restarted.
How to prepare
- Tell the clinician if you have a weakened immune system, eczema or another exfoliative skin condition, or a severe allergy to any vaccine component (the vaccine is produced in chicken embryo cells and contains traces of antibiotics).
- If you are seeking vaccination after an exposure, say so — timing changes the advice.
What to expect afterwards
Redness, swelling, itching and a firm bump at the injection site are common and can last for days to weeks; tiredness, headache and muscle aches can occur.
A lasting small bump or discolouration at the site is possible.
Who should not get it, or should ask first
- Anyone with a severe allergic reaction to a previous JYNNEOS dose or component should not receive it.
- People with weakened immune systems can usually receive JYNNEOS (it cannot replicate), but the response may be weaker — discuss with the clinician.
- Two doses are needed for full protection; one dose gives partial protection only.
Benefits
- Substantially reduces the chance of mpox infection and of severe disease in those infected after vaccination.
- Can prevent or lessen disease when given promptly after exposure.
Limits and possible harms
- Local reactions are common and can be persistent for some weeks.
- Protection is not absolute — vaccinated people can still catch mpox, usually more mildly, so exposure precautions still matter during outbreaks.
Useful links and tools
More in Adult Vaccines
- Tetanus Boosters for Adults (Td & Tdap)
- Shingles Vaccine (Shingrix, RZV)
- Pneumococcal Vaccine for Adults (PCV)
- RSV Vaccine for Older Adults
Frequently asked questions
Is the mpox vaccine the same as the smallpox vaccine?
They are related but different products. JYNNEOS uses modified vaccinia Ankara, a virus weakened so it cannot copy itself in human cells. It is safer for people with weakened immune systems or eczema than the older replicating smallpox vaccine (ACAM2000), which is kept for specific military and laboratory uses.
How soon after exposure should the mpox vaccine be given?
As soon as possible: CDC guidance is that vaccination within 4 days of exposure may prevent the disease, and vaccination between 4 and 14 days may still reduce its severity. Contact a clinic or health department immediately after a known exposure rather than waiting.
This guide explains how a vaccine is usually given and who it is generally offered to, following the CDC immunization schedules. It is general educational information only — not medical advice, and not a recommendation for you personally. Whether a vaccine is right for you depends on your age, health and history, so talk to your own clinician or pharmacist. If you are ill now, seek medical care promptly rather than waiting for a vaccination appointment.